IRF9 antibody (N-Term)
Quick Overview for IRF9 antibody (N-Term) (ABIN2797511)
Target
See all IRF9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 75-104, N-Term
-
Purpose
- Rabbit Anti-Mouse IRF9 (N-term) Antibody
-
Immunogen
- This IRF9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 75-104 amino acids from the N-terminal region of human IRF9.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
-
Western Blot, Immunohistochemistry, Immunofluorescence
Recommended Dilutions
WB: 1:1000, IHC: 1:10-50, IF: 1:10-50IRF9 Antibody (N-term) . -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.280 mg/mL
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C (short-term), -20°C (long-term)
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Alternative Name
- IRF9
-
Background
-
Target Description: IRF9 is a transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.
Gene Symbol: IRF9
-
Molecular Weight
- 43696 Da
-
Gene ID
- 10379
-
UniProt
- Q00978
-
Pathways
- JAK-STAT Signaling, Interferon-gamma Pathway, Hepatitis C
Target
-